← Back to all trials
Not Yet Recruiting
NCT05731284
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
Conditions: Pelvic Organ Prolapse
Sex: Female
Ages: 18 Years – N/A
Phase: NA
Enrollment: 60
Sponsor: University of Alabama at Birmingham
Location: United States
Summary
The purpose of the study is to evaluate the surgical outcomes of injecting platelet-rich plasma (PRP) into the vaginal tissue as an adjunct therapy at the time of prolapse surgery
Eligibility Criteria
Inclusion Criteria:Desire surgical treatment via a transvaginal native tissue approach.Completed child-bearingExclusion Criteria:Unable to follow-up, not willing to, or unable to participate in the proposed studyPrior pelvic surgery within the past 12 monthsPrior anterior/apical suspension proceduresPrior graft augmented prolapse surgeryPelvic/abdominal radiationPelvic massHistory of solid organ malignancy
Source: ClinicalTrials.gov (NCT05731284). StuddyBuddy aggregates publicly available trial information.
